CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 88 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2020. The put-call ratio across all filers is 0.11 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,550,000 | -17.8% | 13,086 | -18.0% | 0.00% | – |
| Q4 2020 | $1,885,000 | +547.8% | 15,956 | +509.0% | 0.00% | – |
| Q3 2020 | $291,000 | +2.8% | 2,620 | -5.7% | 0.00% | – |
| Q2 2020 | $283,000 | -54.8% | 2,777 | -52.2% | 0.00% | – |
| Q1 2020 | $626,000 | +50.1% | 5,807 | +61.8% | 0.00% | – |
| Q4 2019 | $417,000 | -50.8% | 3,588 | -51.5% | 0.00% | – |
| Q3 2019 | $848,000 | +152.4% | 7,401 | +109.7% | 0.00% | – |
| Q2 2019 | $336,000 | -37.7% | 3,529 | -40.2% | 0.00% | – |
| Q1 2019 | $539,000 | +97.4% | 5,902 | +64.0% | 0.00% | – |
| Q4 2018 | $273,000 | -34.2% | 3,599 | -30.6% | 0.00% | – |
| Q3 2018 | $415,000 | -62.3% | 5,189 | -53.2% | 0.00% | – |
| Q2 2018 | $1,102,000 | -88.3% | 11,094 | -90.4% | 0.00% | -100.0% |
| Q1 2018 | $9,381,000 | -38.6% | 115,800 | -40.3% | 0.00% | -25.0% |
| Q4 2017 | $15,275,000 | +66.0% | 193,921 | +94.4% | 0.00% | +33.3% |
| Q3 2017 | $9,203,000 | – | 99,738 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VERNIER CAPITAL PARTNERS, LP | 137,557 | $11,142,000 | 6.62% |
| COMGEST GLOBAL INVESTORS S.A.S. | 637,752 | $51,658,000 | 1.13% |
| Black Creek Investment Management Inc. | 411,525 | $33,334,000 | 1.09% |
| Hillhouse Capital Management | 618,391 | $50,090,000 | 0.88% |
| RUDMAN ERROL M | 21,301 | $1,725,000 | 0.83% |
| JUPITER ASSET MANAGEMENT LTD | 263,705 | $21,360,000 | 0.65% |
| York Capital Management Global Advisors, LLC | 341,616 | $27,671,000 | 0.62% |
| VONTOBEL ASSET MANAGEMENT INC | 873,968 | $71,525,000 | 0.51% |
| Temasek Holdings (Private) Ltd | 990,000 | $80,190,000 | 0.44% |
| WASATCH ADVISORS LP | 292,216 | $23,669,000 | 0.31% |